# Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/durvalumab-plus-platinum-etoposide-versus-platinum-etoposide-in-first-line/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Luis Paz‐Ares,Mikhail Dvorkin,Yuanbin Chen,Niels Reinmuth,Katsuyuki Hotta,Dmytro Trukhin,Galina Statsenko,Maximilian J. Hochmair,Mustafa Özgüroğlu,Jun Ho Ji,Олександр Войтко,Artem Poltoratskiy,Santiago Ponce,Francesco Verderame,Libor Havel,Igor Bondarenko,Andrzej Każarnowicz,György Losonczy,Nikolay Conev,J. Armstrong,Natalie Byrne,Norah J. Shire,Haiyi Jiang,Jonathan W. Goldman,Emilio Batagelj,Ignacio Casarini,Anea Viviana Pastor,S. Sena,Juan José Zarbá,Otto C. Burghuber,Sylvia Hartl,Maximilian J. Hochmair,Bernd Lamprecht,Michael Studnicka,Luís Alberto Schlittler,Fabrício Augusto Martinelli de Oliveira,Aknar Calabrich,Gustavo Girotto,Peo Dos Reis,Carlos Fausto Nino Gorini,Peo Rafael Martins De Marchi,Clarissa Baldotto,Cláudia Vaz de Melo Sette,Mauro Zukin,Nikolay Conev,Assen Dudov,Rumyana Ilieva,Krassimir Koynov,Rositsa Krasteva,Ivan Tonev,Spartak Valev,Violetka Venkova,Minghong Bi,Chengshui Chen,Yuan Chen,Zhendong Chen,Jian Fang,Jifeng Feng,Zhigang Han,Jie Hu,Yi Hu,Xing Li,Zongan Liang,Lin Zhong,Rui Ma,Shenglin Ma,Kejun Nan,Yongqian Shu,Kai Wang,Mengzhao Wang,Gang Wu,Nong Yang,Zhixiong Yang,Helong Zhang,Wei Zhang,Jun Zhao,Yanqiu Zhao,Caicun Zhou,Jianying Zhou,Xiangdong Zhou,Libor Havel,Vı́tězslav Kolek,Leona Koubková,Jaromı́r Roubec,Jana Skřičková,Milada Zemanová,C. Chouaïd,Werner Hilgers,H. Léna,Denis Moro‐Sibilot,G. Robinet,Pierre-Jean Souquet,Jürgen Alt,Helge Bischoff,Christian Grohé,Eckart Laack,Susanne Lang,Jens Panse,Niels Reinmuth,Christian Schulz |
| Citations | 2,246 |
| DOI | 10.1016/s0140-6736(19)32222-6 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2977392388 |
| PMID | 31590988 |
| Type | article |
| Year | 2019 |

## Paper authors

Showing 10 of 13.

- [Denis Moro‐Sibilot](https://scholariq.org/researchers/denis-moro-sibilot/)
- [Jonathan W. Goldman](https://scholariq.org/researchers/jonathan-w-goldman/)
- [Xing Li](https://scholariq.org/researchers/xing-li/)
- [Christian Grohé](https://scholariq.org/researchers/christian-grohe/)
- [Nong Yang](https://scholariq.org/researchers/nong-yang-2/)
- [Afshin Dowlati](https://scholariq.org/researchers/afshin-dowlati/)
- [Kōichi Goto](https://scholariq.org/researchers/koichi-goto/)
- [Te‐Chun Hsia](https://scholariq.org/researchers/te-chun-hsia/)
- [Marina Chiara Garassino](https://scholariq.org/researchers/marina-chiara-garassino/)
- [David R. Spigel](https://scholariq.org/researchers/david-r-spigel/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Paper topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.